dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Aqueductal Stenosis

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Aqueductal Stenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Trials

1 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Aqueductal Stenosis

Article	Year
Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. The Online journal of current clinical trials, 1992, Nov-10, Volume: Doc No 28 Topics: Brain Diseases; Cysts; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome; Ultrasonography	1992

Article

Year

Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.

The Online journal of current clinical trials, 1992, Nov-10, Volume: Doc No 28

Topics: Brain Diseases; Cysts; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hydrocephalus; Infant, Newborn; Infant, Premature; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome; Ultrasonography

1992